Benchling Raises $50M in Series D Funding
Summary
The company intends to use the funds to build advanced product capabilities, expand its international presence, and drive adoption across leading R&D organizations. Led by Saji Wickramasekara, CEO and founder, Benchling provides an R&D cloud platform powering the life science industry. It offers unified R&D solutions purpose-built for biotech, including Notebook, Molecular Biology, Registry, Inventory, Request & Workflow Management, and Insights. The solution is used globally across the largest multinational pharmaceutical corporations, emerging biotechnology companies, and renowned research institutions. Since launching in 2012, more than 230,000 scientists and 1,000 R&D organizations have adopted it to centralize complex experimental datasets and optimize R&D processes.
Funding
Review available funding amount, funding date, investors, and linked company information related to Benchling Raises $50M in Series D Funding in the interactive ISVWorld profile.